|EGFR (Cell-free assay)||HER2 (Cell-free assay)||PDGFR (Cell-free assay)|
|3 nM||>100 μM||>100 μM|
|In vitro (25°C)||DMSO||25 mg/mL (79.17 mM)|
|Water||<1 mg/mL (<1 mM)|
|Ethanol||13 mg/mL (41.17 mM)|
|In vivo||15% Captisol||15% Captisol|
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||31.67 mL||158.33 mL||316.66 mL|
|0.5 mM||6.33 mL||31.67 mL||63.33 mL|
|1 mM||3.17 mL||15.83 mL||31.67 mL|
|5 mM||0.63 mL||3.17 mL||6.33 mL|
*The above data is based on the productmolecular weight 315.8 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
|Synonyms||AG1478, AG 1478|
WZ3146 is an inhibitor of EGFR receptor kinase mutants carrying a mutation in an active site gatekeeper residue (T790M) and is much less pot…
Lapatinib is a dual tyrosine kinase inhibitor which interrupts the HER2 growth receptor pathway.
AEE788 is an orally bioavailable multiple-receptor tyrosine kinase inhibitor that inhibits phosphorylation of the tyrosine kinases of EGFR, …
Icotinib hydrochloride is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an IC(50) of 5 …
OSI-420 (Desmethyl Erlotinib,CP-473420) is an orally active EGFR tyrosin kinase inhibitor, which inhibits receptor tyrosine kinases (TKs) by…
TAK-285 is an investigational HER2/EGFR inhibitor that penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB). TAK-285 has inhi…